Startseite Immunoassay of thyroid peroxidase autoantibodies: diagnostic performance in automated third generation methods. A multicentre evaluation
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Immunoassay of thyroid peroxidase autoantibodies: diagnostic performance in automated third generation methods. A multicentre evaluation

  • Federica D’Aurizio EMAIL logo , Renato Tozzoli , Danilo Villalta , Giampaola Pesce und Marcello Bagnasco
Veröffentlicht/Copyright: 2. Oktober 2014
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: The use of automated immunometric methods for the detection of anti-thyroid peroxidase antibodies (TPOAb), the main serological marker of autoimmune thyroid diseases (AITD), has expanded in recent years. However, it is not known whether these new automated platforms have improved the diagnostic performance of TPOAb assays. The aim of this study was to evaluate the potential improvement of the inter-method agreement of current automated third generation systems, 12 years after a previous study, which had assessed the analytical variability between semi-automated second generation methods of TPOAb detection.

Methods: Eight pools of sera from patients with chronic lymphocytic thyroiditis, exhibiting different TPOAb concentrations, were collected from routine laboratory diagnostics and distributed to seven companies throughout Italy. All automated third generation methods were calibrated against the Medical Research Council (MRC) reference preparation 66/387.

Results: The overall mean variability (CV) was 93.6% when results were expressed in part as arbitrary Units (U/mL) and in part as International Units (IU/mL). The conversion of all values in IU/mL resulted in a significant decrease of CV (49.8%). The CV expressed as COM (cut-off concentration multiples) was 64.0%. Agreement of qualitative results was 95.3% with a pronounced difference in the threshold values proposed by manufacturers (range 3.2–35.0 IU/mL).

Conclusions: These findings confirm the improvement of harmonisation between different methods of automated third generation TPOAb assays. Nevertheless, further efforts should be made in the definition of the positive cut-off concentration to avoid misclassification of AITD patients as well as in a new international reference preparation and in the autoantigen purification modality.


Corresponding author: Federica D’Aurizio, MD, Laboratory of Clinical Pathology, Department of Laboratory Medicine, ‘S. Maria degli Angeli’ Hospital, Via Montereale, 24, 33170 Pordenone, Italy, Phone: +39 0434-399213, Fax: +39 0434-399906, E-mail:

Acknowledgments

The authors thank companies and laboratories that contributed to the study.

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Financial support: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organisation(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Tozzoli R, Villalta D, Kodermaz G, Bagnasco M, Tonutti E, Bizzaro N. Autoantibody profiling of patients with autoimmune thyroid disease using a new multiplexed immunoassay method. Clin Chem Lab Med 2006;44:837–42.10.1515/CCLM.2006.137Suche in Google Scholar PubMed

2. Czarnocka B, Cocks Eschler D, Godlewska M, Tomer Y. Thyroid autoantibodies: thyroid peroxidase and thyroglobulin antibodies. In: Shoenfeld Y, Meroni PL, Gershwin ME, editors. Autoantibodies, 3rd ed. Amsterdam: Elsevier, 2014:365–73.Suche in Google Scholar

3. Tozzoli R, Bagnasco M, Villalta D. Thyrotropin receptor antibodies. In: Shoenfeld Y, Meroni PL, Gershwin ME, editors. Autoantibodies, 3rd ed. Amsterdam: Elsevier, 2014:375–83.Suche in Google Scholar

4. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman E, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and post-partum. Thyroid 2011;21:1081–125.10.1089/thy.2011.0087Suche in Google Scholar PubMed PubMed Central

5. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011;21:593–647.10.1089/thy.2010.0417Suche in Google Scholar PubMed

6. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanock JI, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012;18:988–1028.10.4158/EP12280.GLSuche in Google Scholar PubMed

7. Baloch Z, Carayon P, Comte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3–126.10.1089/105072503321086962Suche in Google Scholar PubMed

8. Brenta G, Vaisman M, Sgarbi JA, Bergoglio LM, Carvalho de Andrada N, Pineda Bravo P, et al. Clinical practice guidelines for the management of hypothyroidism. Aeq Bras Endocrinol Metab 2013;57:265–99.10.1590/S0004-27302013000400003Suche in Google Scholar

9. Czarnocka B. Thyroperoxidase, thyroglobulin, Na(+)/I(+) symporter, pendrin in thyroid autoimmunity. Front Biosci 2011;16:783–802.10.2741/3720Suche in Google Scholar PubMed

10. McLachlan SM, Rapoport B. Thyroid peroxidase as an autoantigen. Thyroid 2007;17:939–48.10.1089/thy.2007.0169Suche in Google Scholar PubMed

11. Tozzoli R, Bonaguri C, Melegari A, Antico A, Bassetti D, Bizzaro N. Current state of diagnostic technologies in the autoimmunology laboratory. Clin Chem Lab Med 2013;51:129–38.10.1515/cclm-2012-0191Suche in Google Scholar PubMed

12. La’ulu SL, Slev PR, Roberts WL. Performance characteristics of 5 automated thyroglobulin and thyroperoxidase autoantibody assays. Clin Chim Acta 2007;376:88–95.10.1016/j.cca.2006.07.018Suche in Google Scholar PubMed

13. Gonzalez C, Garcia-Berrocal B, Talavan T, Casas ML, Navajo JA, Gonzalez-Buitrago JM. Clinical evaluation of a microsphere bead-based flow cytometry assay for the simultaneous determination of anti-thyroid peroxidase and anti-thyroglobulin antibodies. Clin Biochem 2005;38:966–72.10.1016/j.clinbiochem.2005.08.004Suche in Google Scholar PubMed

14. Kivity S, Agmon-Levin N, Zisappl M, Shapira Y, Nagy EV, Danko K, et al. Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol 2011;8:243–7.10.1038/cmi.2010.73Suche in Google Scholar PubMed PubMed Central

15. Tozzoli R, Bizzaro N, Tonutti E, Pradella M, Manoni F, Villalta D, et al. Immunoassay of anti-thyroid autoantibodies: high analytical variability in second generation methods. Clin Chem Lab Med 2002;40:568–73.10.1515/CCLM.2002.098Suche in Google Scholar PubMed

16. Tozzoli R, Giavarina D, Villalta D, Soffiati G, Bizzaro N. Definition of reference limits for autoantibodies to thyroid peroxidase and thyroglobulin in a large population of outpatients using an indirect method based on current data. Arch Pathol Lab Med 2008;132:1924–8.10.5858/132.12.1924Suche in Google Scholar PubMed

17. Sinclair D. Analytical aspects of thyroid antibodies estimation. Autoimmunity 2008;41:46–54.10.1080/08916930701619466Suche in Google Scholar PubMed

18. Libert F, Ruel J, Ludgate M, Swillens S, Alexander N, Vassart G, et al. Thyroperoxidase, an auto-antigen with a mosaic structure made of nuclear and mitochondrial gene modules. EMBO J 1987;6:4193–6.10.1002/j.1460-2075.1987.tb02766.xSuche in Google Scholar PubMed PubMed Central

19. Ruf J, Toubert ME, Czarnocka B, Durand-Gorde JM, Ferrand M, Carayon P. Relationship between immunological structure and biochemical properties of human thyroid peroxidase. Endocrinology 1989;125:1211–8.10.1210/endo-125-3-1211Suche in Google Scholar PubMed

20. Jastrzebska-Bohaterewicz E, Gardas A. Proportion of antibodies to the A and B immunodominant regions of thyroid peroxidase in Graves and Hashimoto disease. Autoimmunity 2004;37:211–6.10.1080/0891693042000193339Suche in Google Scholar PubMed

21. Bresson D, Rebuffat SA, Banga JP, Gardas A, Peraldi-Roux S. New insights into the conformational dominant epitopes on thyroid peroxidase recognized by human autoantibodies. Endocrinology 2005;146:2834–44.10.1210/en.2005-0038Suche in Google Scholar PubMed

22. Dubska M, Banga JP, Plochocka D, Hoser G, Kemp EH, Sutton BJ, et al. Structural insights into autoreactive determinants in thyroid peroxidase composed of discontinuous and multiple key contact amino acid residues contributing to epitopes recognized by patients’ autoantibodies. Endocrinology 2006;147:5995–6003.10.1210/en.2006-0912Suche in Google Scholar PubMed

23. Nielsen CH, Brix TH, Gardas A, Banga JP, Hegedus L. Epitope recognition patterns of thyroid peroxidase autoantibodies in healthy individuals and patients with Hashimoto’s thyroiditis. Clin Endocrinol 2008;69:664–8.10.1111/j.1365-2265.2008.03245.xSuche in Google Scholar PubMed

24. Godlewska M, Czarnocka B, Gora M. Localization of key amino-acid residues in the dominant conformational epitopes on thyroid peroxidase recognized by monoclonal antibodies. Autoimmunity 2012;45:476–84.10.3109/08916934.2012.682667Suche in Google Scholar PubMed

25. Burek CI, Rose NR, Caturegli P. Thyroglobulin, thyroperoxidase, and thyrotropin-receptor autoantibodies. In: Shoenfeld Y, Gershwin ME, Meroni PL, editors. Autoantibodies, 2nd ed. Amsterdam: Elsevier, 2007:403–14.Suche in Google Scholar

26. Godlewska M, Gora M, Buckle AM, Porebski BT, Kemp EH, Sutton BJ, et al. A redundant role of human thyroid peroxidase propeptide for cellular, enzymatic and immunological activity. Thyroid 2014;24:371–82.10.1089/thy.2013.0127Suche in Google Scholar PubMed PubMed Central

27. Liu M-M, Li Q, Zhao L-L, Gao Y, Huang Y-Y, Lu G-Z, et al. Glycosylation of recombinant human thyroid peroxidase ectodomain of insect cell origin has little effect on recognition by serum thyroid peroxidase antibody. Chin Med J 2013;126:2907–11.Suche in Google Scholar

Supplemental Material: The online version of this article (DOI: 10.1515/cclm-2014-0545) offers supplementary material, available to authorized users.Suche in Google Scholar


Supplemental Material

The online version of this article (DOI: 10.1515/cclm-2014-0545) offers supplementary material, available to authorized users.


Received: 2014-5-23
Accepted: 2014-8-25
Published Online: 2014-10-2
Published in Print: 2015-2-1

©2015 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Editorials
  3. Variable accuracy of home pregnancy tests: truth in advertising?
  4. The highs and lows of tumor biomarkers: lost illusions
  5. Mini Review
  6. Matrix metalloproteinases as biomarkers of disease: updates and new insights
  7. Opinion Papers
  8. Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE)
  9. Colour coding for blood collection tube closures – a call for harmonisation
  10. Harmonization protocols for thyroid stimulating hormone (TSH) immunoassays: different approaches based on the consensus mean value
  11. Genetics and Molecular Diagnostics
  12. Detection of HLA-B*58:01 with TaqMan assay and its association with allopurinol-induced sCADR
  13. General Clinical Chemistry and Laboratory Medicine
  14. Comparison of analytical sensitivity and women’s interpretation of home pregnancy tests
  15. Accuracy of GFR estimating equations combining standardized cystatin C and creatinine assays: a cross-sectional study in Sweden
  16. Immunoassay of thyroid peroxidase autoantibodies: diagnostic performance in automated third generation methods. A multicentre evaluation
  17. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens
  18. Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots
  19. One year B-vitamins increases serum and whole blood folate forms and lowers plasma homocysteine in older Germans
  20. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study
  21. Reference Values and Biological Variations
  22. Salivary morning androstenedione and 17α-OH progesterone levels in childhood and puberty in patients with classic congenital adrenal hyperplasia
  23. The baseline serum value of α-amylase is a significant predictor of distance running performance
  24. Cancer Diagnostics
  25. Urinary thiosulfate as failed prostate cancer biomarker – an exemplary multicenter re-evaluation study
  26. Clinical utility of determining tumor markers in patients with signs and symptoms of cancer
  27. Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients
  28. The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer
  29. Cardiovascular Diseases
  30. Predictive value for death and rehospitalization of 30-day postdischarge B-type natriuretic peptide (BNP) in elderly patients with heart failure. Sub-analysis of Italian RED Study
  31. Letters to the Editors
  32. Pre-analytical stability of 25(OH)-vitamin D in primary collection tubes
  33. Effects of lipemia on osmolality in native lipemic material and intravenous lipid emulsion added sera
  34. Does creatinine analytical performance support robust identification of acute kidney injury within individual laboratories in a region
  35. High serum amylase levels may reflect a wide spectrum of health benefits
  36. Optimal cut-off concentration for a faecal immunochemical test for haemoglobin by Hemo Techt NS-Plus C15 system for the colorectal cancer screening
  37. MTHFR C677T allelic variant is not associated with plasma and cerebrospinal fluid homocysteine in amyotrophic lateral sclerosis
  38. Analytical assessment of bone serum markers in patients suffering from spina bifida
  39. Serum concentrations and urinary excretion of homogentisic acid and tyrosine in normal subjects
Heruntergeladen am 10.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2014-0545/html
Button zum nach oben scrollen